Cargando…
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
BACKGROUND: A recently discovered occult HCV entity reported by various investigators seems to be highly controversial. Especially, the clinical significance of these findings remains uncertain. For optimal outcome of antiviral therapy, investigation of occult HCV needs a broad-based probe in order...
Autores principales: | Muazzam, Ambreen G, Qureshi, Saleem, Mansoor, Atika, Ali, Lubna, Iqbal, Musarrat, Siddiqi, Saima, Khan, Khalid M, Mazhar, Kehkashan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184037/ https://www.ncbi.nlm.nih.gov/pubmed/21892969 http://dx.doi.org/10.1186/1479-0556-9-14 |
Ejemplares similares
-
Association of HLA-DRB1 and -DQB1alleles and haplotypes with rheumatoid arthritis in a Pakistani population
por: Muazzam, Ambreen Gul, et al.
Publicado: (2013) -
Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population
por: Mansoor, Atika, et al.
Publicado: (2013) -
Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance
por: Manickam, Cordelia, et al.
Publicado: (2019) -
Occult HCV Infection: The Current State of Knowledge
por: Rezaee-Zavareh, Mohammad Saeid, et al.
Publicado: (2015) -
HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)